Loading...

Eviana Health

CNSX:EHC
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EHC
CNSX
CA$15M
Market Cap
  1. Home
  2. CA
  3. Materials
Company description

Eviana Health Corporation produces and sells cannabinoid products from natural hemp strains of cannabis sativa for medical, beauty and grooming, vitamins and supplements, fitness, food and beverage, and pet markets. The last earnings update was 16 days ago. More info.


Add to Portfolio Compare Print
  • Eviana Health has significant price volatility in the past 3 months.
EHC Share Price and Events
7 Day Returns
3.3%
CNSX:EHC
-0.3%
CA Chemicals
0.9%
CA Market
1 Year Returns
-65.6%
CNSX:EHC
10.7%
CA Chemicals
1.2%
CA Market
EHC Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Eviana Health (EHC) 3.3% 6.9% 5.1% -65.6% - -
CA Chemicals -0.3% 0.9% 15.8% 10.7% 44.9% -4.8%
CA Market 0.9% 2.3% 12.4% 1.2% 16.1% 5.9%
1 Year Return vs Industry and Market
  • EHC underperformed the Chemicals industry which returned 10.7% over the past year.
  • EHC underperformed the Market in Canada which returned 1.2% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

EHC Value

 Is Eviana Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Eviana Health. This is due to cash flow or dividend data being unavailable. The share price is CA$0.62.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Eviana Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Eviana Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:EHC PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CAD CA$-0.16
CNSX:EHC Share Price ** CNSX (2019-03-19) in CAD CA$0.62
Canada Chemicals Industry PE Ratio Median Figure of 6 Publicly-Listed Chemicals Companies 8.99x
Canada Market PE Ratio Median Figure of 542 Publicly-Listed Companies 14.83x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Eviana Health.

CNSX:EHC PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:EHC Share Price ÷ EPS (both in CAD)

= 0.62 ÷ -0.16

-3.87x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eviana Health is loss making, we can't compare its value to the CA Chemicals industry average.
  • Eviana Health is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Eviana Health's expected growth come at a high price?
Raw Data
CNSX:EHC PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -3.87x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Chemicals Industry PEG Ratio Median Figure of 49 Publicly-Listed Chemicals Companies 1.45x
Canada Market PEG Ratio Median Figure of 252 Publicly-Listed Companies 1.21x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Eviana Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Eviana Health's assets?
Raw Data
CNSX:EHC PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CAD CA$0.26
CNSX:EHC Share Price * CNSX (2019-03-19) in CAD CA$0.62
Canada Chemicals Industry PB Ratio Median Figure of 29 Publicly-Listed Chemicals Companies 1.34x
Canada Market PB Ratio Median Figure of 2,347 Publicly-Listed Companies 1.56x
CNSX:EHC PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:EHC Share Price ÷ Book Value per Share (both in CAD)

= 0.62 ÷ 0.26

2.41x

* Primary Listing of Eviana Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eviana Health is overvalued based on assets compared to the CA Chemicals industry average.
X
Value checks
We assess Eviana Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Eviana Health has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

EHC Future Performance

 How is Eviana Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eviana Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
28.6%
Expected Chemicals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Eviana Health expected to grow at an attractive rate?
  • Unable to compare Eviana Health's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Eviana Health's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Eviana Health's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:EHC Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 28.6%
Canada Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.2%
Canada Market Earnings Growth Rate Market Cap Weighted Average 17.9%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:EHC Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:EHC Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2018-12-31 0 -4 -4
2018-09-30 0 -3 -2
2018-06-30 0 -2 -5
2018-03-31 -1 -5
2017-06-30 0 -1
2016-06-30 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Eviana Health is high growth as no earnings estimate data is available.
  • Unable to determine if Eviana Health is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:EHC Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Eviana Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:EHC Past Financials Data
Date (Data in CAD Millions) EPS *
2018-12-31 -0.16
2018-09-30 -0.11
2018-06-30 -0.23
2018-03-31 -0.29
2017-06-30 -0.08
2016-06-30 0.00

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Eviana Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Eviana Health's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Eviana Health's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Materials companies here
  3. Eviana Health's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Eviana Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Eviana Health has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

EHC Past Performance

  How has Eviana Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Eviana Health's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Eviana Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Eviana Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Eviana Health's 1-year growth to the North America Chemicals industry average as it is not currently profitable.
Earnings and Revenue History
Eviana Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Eviana Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:EHC Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 0.09 -3.74 3.54
2018-09-30 0.09 -2.42 2.46
2018-06-30 0.09 -4.83 4.42
2018-03-31 -5.35 3.97
2017-06-30 -1.24 0.03
2016-06-30 0.00 0.00
2015-06-30 0.00 0.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Eviana Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Eviana Health has efficiently used its assets last year compared to the CA Chemicals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Eviana Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Eviana Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Eviana Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

EHC Health

 How is Eviana Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Eviana Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Eviana Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Eviana Health's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Eviana Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Eviana Health Company Filings, last reported 2 months ago.

CNSX:EHC Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 6.15 7.77 8.68
2018-09-30 5.34 0.03 0.95
2018-06-30 5.79 0.05 3.03
2018-03-31 7.13 0.00 3.89
2017-06-30 -0.15 0.80 0.19
2016-06-30 0.91 0.23 0.00
2015-06-30 0.91 0.23
  • Eviana Health's level of debt (126.3%) compared to net worth is high (greater than 40%).
  • Unable to establish if Eviana Health's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Eviana Health has sufficient cash runway for 1.6 years based on current free cash flow.
  • Eviana Health has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 93.5% each year.
X
Financial health checks
We assess Eviana Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Eviana Health has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

EHC Dividends

 What is Eviana Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Eviana Health dividends.
If you bought CA$2,000 of Eviana Health shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Eviana Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Eviana Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:EHC Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 55 Stocks 2.3%
Canada Market Average Dividend Yield Market Cap Weighted Average of 330 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Eviana Health has not reported any payouts.
  • Unable to verify if Eviana Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Eviana Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Eviana Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Eviana Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Eviana Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Eviana Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

EHC Management

 What is the CEO of Eviana Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Avram Adizes
COMPENSATION CA$120,000
TENURE AS CEO 1.6 years
CEO Bio

Dr. Avram Adizes, Ph.D., P.E., serves as the Chief Technology Officer of Phoenix Capital Partners Inc. Dr. Adizes is responsible for Technology assessment and evaluation. Dr. Adizes serves as Chairman and Chief Executive Officer of Eviana Health Corporation. Dr. Adizes has over 30 years' experience in R&D. Dr. Adizes established projects in fields of public health systems, medical digital image technology for diagnostic purposes, directed development of Security Infrastructure according to International standards, allowing Governments and Businesses to communicate electronically with the general public and internally. Since December 2002, he has been a member of DSA a US Homeland Document Security Advisory Board with US Secret Service.

CEO Compensation
  • Insufficient data for Avram to compare compensation growth.
  • Avram's remuneration is about average for companies of similar size in Canada.
Management Team

Avram Adizes

TITLE
Chairman of the Board & CEO
COMPENSATION
CA$120K
TENURE
1.6 yrs

Sydney, Syd Au

TITLE
CFO & Director
COMPENSATION
CA$60K

Patrick Brown

TITLE
Vice-President of Business Development & Corporate Communications
TENURE
0.8 yrs
Board of Directors Tenure

Average tenure of the Eviana Health board of directors in years:

1.6
Average Tenure
  • The average tenure for the Eviana Health board of directors is less than 3 years, this suggests a new board.
Board of Directors

Avram Adizes

TITLE
Chairman of the Board & CEO
COMPENSATION
CA$120K
TENURE
1.6 yrs

Sydney, Syd Au

TITLE
CFO & Director
COMPENSATION
CA$60K
TENURE
5.8 yrs

Ljiljana Vujotic

TITLE
Director
COMPENSATION
CA$100K
TENURE
1.6 yrs

Joel Sherlock

TITLE
Member of Advisory Board
TENURE
0.7 yrs

Paolo De Luca

TITLE
Director
AGE
45
TENURE
0.4 yrs
Who owns this company?
Recent Insider Trading
  • Eviana Health insiders have only sold shares in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
28. Jan 19 Sell Olivier Robert Benloulou Individual 25. Jan 19 25. Jan 19 -10,000 CA$0.75 CA$-7,500
31. Oct 18 Sell Olivier Robert Benloulou Individual 29. Oct 18 29. Oct 18 -65,800 CA$0.85 CA$-55,930
X
Management checks
We assess Eviana Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Eviana Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

EHC News

Simply Wall St News

Are Insiders Selling Eviana Health Corporation (CNSX:EHC) Stock?

So before you buy or sell Eviana Health Corporation (CNSX:EHC), you may well want to know whether insiders have been buying or selling. … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … The Last 12 Months Of Insider Transactions At Eviana Health

Simply Wall St -

Why Eviana Health Corporation's (CNSX:EHC) Ownership Structure Is Important

In this article, I will take a quick look at Eviana Health Corporation’s (CNSX:EHC) recent ownership structure – an unconventional investing subject, but an important one. … When it comes to ownership structure of a company, the impact has been observed in both the long-and short-term performance of shares. … The effect of an active institutional investor with a similar ownership as a passive pension-fund can be vastly different on a company's corporate governance and accountability to shareholders.

Simply Wall St -

EHC Company Info

Description

Eviana Health Corporation produces and sells cannabinoid products from natural hemp strains of cannabis sativa for medical, beauty and grooming, vitamins and supplements, fitness, food and beverage, and pet markets. It is also involved in the growing of industrial hemp and extraction of cannabidiol. The company was formerly known as C&C Cosmeceuticals Corp. and changed its name to Eviana Health Corporation in May 2017. Eviana Health Corporation was incorporated in 2011 and is headquartered in Vancouver, Canada.

Details
Name: Eviana Health Corporation
EHC
Exchange: CNSX
Founded: 2011
CA$14,817,906
23,899,849
Website: http://eviana.ca
Address: Eviana Health Corporation
5728 East Boulevard,
Vancouver,
British Columbia, V6M 4M4,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX EHC Common Shares Canadian National Stock Exchange CA CAD 12. Sep 2017
OTCPK EVNN.F Common Shares Pink Sheets LLC US USD 12. Sep 2017
DB 1CP Common Shares Deutsche Boerse AG DE EUR 12. Sep 2017
Number of employees
Current staff
Staff numbers
0
Eviana Health employees.
Industry
Specialty Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/03/20 00:44
End of day share price update: 2019/03/19 00:00
Last earnings filing: 2019/03/04
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.